HLA-DMA
HLA class II histocompatibility antigen, DM alpha chain
Also known as: D6S222E, DMA_HUMAN, RING6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28067
- Gene
- HLA-DMA
- Ensembl
- ENSG00000204257
- Chromosome
- 6
- Canonical length
- 261 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
261 residues, UniProt reviewed canonical sequence.
>P28067|HLA-DMA
1 MGHEQNQGAA LLQMLPLLWL LPHSWAVPEA PTPMWPDDLQ NHTFLHTVYC QDGSPSVGLS
61 EAYDEDQLFF FDFSQNTRVP RLPEFADWAQ EQGDAPAILF DKEFCEWMIQ QIGPKLDGKI
121 PVSRGFPIAE VFTLKPLEFG KPNTLVCFVS NLFPPMLTVN WQHHSVPVEG FGPTFVSAVD
181 GLSFQAFSYL NFTPEPSDIF SCIVTHEIDR YTAIAYWVPR NALPSDLLEN VLCGVAFGLG
241 VLGIIVGIVL IIYFRKPCSG DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-DMA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 119 nTPM
Expression across tissuesHPA
Tissue
- spleen: 119 nTPM
- lung: 97 nTPM
- adipose tissue: 79 nTPM
- small intestine: 67 nTPM
- breast: 63 nTPM
- adrenal gland: 63 nTPM
Single-cell type
- cdc: 734 nCPM
- macrophages: 264 nCPM
- kupffer cells: 262 nCPM
- pdcs: 179 nCPM
- enterocytes: 153 nCPM
- breast lactating cells: 144 nCPM
Immune cell
- myeloid DC: 7.2 nTPM
- memory B-cell: 6.4 nTPM
- naive B-cell: 6.4 nTPM
- plasmacytoid DC: 5.3 nTPM
- classical monocyte: 3.8 nTPM
- intermediate monocyte: 3.8 nTPM
Brain region
- choroid plexus: 1.1 nTPM
- white matter: 1 nTPM
- cerebral cortex: 0.7 nTPM
- medulla oblongata: 0.6 nTPM
- spinal cord: 0.6 nTPM
- midbrain: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.98
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- peptide antigen assembly with MHC class II protein complex
- positive regulation of immune response
- positive regulation of T cell activation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MHC class II, alpha chain, N-terminal
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- MHC class II, alpha/beta chain, N-terminal
- Immunoglobulin-like domain superfamily
- Major Histocompatibility Complex/Immunoglobulin
- Class II histocompatibility antigen, alpha domain
- Immunoglobulin C1-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HLA-DMA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- MHCII
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-DMA as an antibody target. Whether an autoantibody or antibody against HLA-DMA could matter depends on whether native HLA-DMA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-DMA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HLA-DMA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...